Terms: = Skin cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Treatment
163 results:
1. Clinicopathological and immunohistochemical characteristics of bullous pilomatricoma: a retrospective, single-center study, and comparison with ordinary pilomatricoma.
Nam KH; Lee SK; Lee IJ; Park J; Yun SK
An Bras Dermatol; 2024; 99(3):362-369. PubMed ID: 38350760
[TBL] [Abstract] [Full Text] [Related]
2. Decoding the synergistic potential of MAZ-51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals.
Letsoalo K; Nortje E; Patrick S; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2024 Mar; 42(2):e3950. PubMed ID: 38348768
[TBL] [Abstract] [Full Text] [Related]
3. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
Huang WK; Hsu HC; Yang TS; Lu CW; Pan YR; Wu CE; Chung WH; Hung SI; Yeh CN
Eur J Cancer; 2023 Dec; 195():113286. PubMed ID: 37968194
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
5. Vitamin D Modulates the Response of Patient-Derived Metastatic Melanoma Cells to Anticancer Drugs.
Piotrowska A; Zaucha R; Król O; Żmijewski MA
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175742
[TBL] [Abstract] [Full Text] [Related]
6. Exploring the association and causal effect between white blood cells and psoriasis using large-scale population data.
Zhou G; Ren X; Tang Z; Li W; Chen W; He Y; Wei B; Zhang H; Ma F; Chen X; Zhang G; Shen M; Liu H
Front Immunol; 2023; 14():1043380. PubMed ID: 36865550
[TBL] [Abstract] [Full Text] [Related]
7. Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Bannoud N; Stupirski JC; Cagnoni AJ; Hockl PF; Pérez Sáez JM; García PA; Mahmoud YD; Gambarte Tudela J; Scheidegger MA; Marshall A; Corrie PG; Middleton MR; Mariño KV; Girotti MR; Croci DO; Rabinovich GA
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2214350120. PubMed ID: 36634146
[TBL] [Abstract] [Full Text] [Related]
8. Focal adhesion alterations in G0-positive melanoma cells.
Esimbekova AR; Palkina NV; Zinchenko IS; Belenyuk VD; Savchenko AA; Sergeeva EY; Ruksha TG
Cancer Med; 2023 Mar; 12(6):7294-7308. PubMed ID: 36533319
[TBL] [Abstract] [Full Text] [Related]
9. OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
Thiebaud JA; Ravi V; Litwin S; Schuetze SM; Movva S; Agulnik M; Kraft AS; Tetzlaff ED; Somaiah N; von Mehren M
Cancer; 2022 Oct; 128(19):3516-3522. PubMed ID: 35942596
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.
Zhang R; Chen X; Chen S; Tang J; Chen F; Lin Y; Reinach PS; Yan X; Tu L; Duan H; Qu J; Hou Q
Cell Oncol (Dordr); 2022 Aug; 45(4):557-572. PubMed ID: 35716258
[TBL] [Abstract] [Full Text] [Related]
11. Indigenous Nigeria medicinal herbal remedies: A potential source for therapeutic against rheumatoid arthritis.
Arunsi UO; Chioma OE; Etusim PE; Owumi SE
Exp Biol Med (Maywood); 2022 Jul; 247(13):1148-1178. PubMed ID: 35708153
[TBL] [Abstract] [Full Text] [Related]
12. Accelerated Wound Healing and Keratinocyte Proliferation through PI3K/Akt/pS6 and vegfr2 Signaling by Topical Use of Pleural Fluid.
Tsai CL; Changchien CY; Chen Y; Chang HH; Tsai WC; Wang YW; Chou KC; Chiang MH; Tsai YL; Tsai HC; Wang CY; Shen MS; Cheng LT; Lin HY; Yang TB; Chian CF
Cells; 2022 Feb; 11(5):. PubMed ID: 35269438
[TBL] [Abstract] [Full Text] [Related]
13. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/vegfr-2 interaction.
Landras A; Reger de Moura C; Villoutreix BO; Battistella M; Sadoux A; Dumaz N; Menashi S; Fernández-Recio J; Lebbé C; Mourah S
Oncogene; 2022 Apr; 41(15):2254-2264. PubMed ID: 35217792
[TBL] [Abstract] [Full Text] [Related]
14. Nitric oxide in multikinase inhibitor-induced hand-foot skin reaction.
Chen L; Wu Z; Yang L; Chen Y; Wang W; Cheng L; Li C; Lv D; Xia L; Chen J; Tang L; Zhang LI; Zhang S; Luo J
Transl Res; 2022 Jul; 245():82-98. PubMed ID: 35189405
[TBL] [Abstract] [Full Text] [Related]
15. Advances in the drug management of basal cell carcinoma.
Ramelyte E; Restivo G; Mannino M; Levesque MP; Dummer R
Expert Opin Pharmacother; 2022 Apr; 23(5):573-582. PubMed ID: 35081851
[TBL] [Abstract] [Full Text] [Related]
16. Real-World Data: Fruquintinib in Treating Metastatic Colorectal cancer.
Liu S; Lu L; Pan F; Yang C; Liang J; Liu J; Wang J; Shen R; Xin FZ; Zhang N
Oncol Res; 2022 May; 29(1):25-31. PubMed ID: 35063062
[TBL] [Abstract] [Full Text] [Related]
17. Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma.
Tang B; Mo J; Yan X; Duan R; Chi Z; Cui C; Si L; Kong Y; Mao L; Li S; Zhou L; Lian B; Wang X; Bai X; Xu H; Li C; Dai J; Guo J; Sheng X
Eur J Cancer; 2021 Oct; 156():83-92. PubMed ID: 34425407
[TBL] [Abstract] [Full Text] [Related]
18. PD-1 inhibitor combined with apatinib modulate the tumor microenvironment and potentiate anti-tumor effect in mice bearing gastric cancer.
Chen H; Jiang T; Lin F; Guan H; Zheng J; Liu Q; Du B; Huang Y; Lin X
Int Immunopharmacol; 2021 Oct; 99():107929. PubMed ID: 34343940
[TBL] [Abstract] [Full Text] [Related]
19. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
Zou S; Gao Y; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
[TBL] [Abstract] [Full Text] [Related]
20. Identification ACTA2 and kdr as key proteins for prognosis of PD-1/PD-L1 blockade therapy in melanoma.
Wang Y; Li Z; Zhang Z; Chen X
Animal Model Exp Med; 2021 Jun; 4(2):138-150. PubMed ID: 34179721
[TBL] [Abstract] [Full Text] [Related]
[Next]
